These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20596062)

  • 21. Routine anticoagulation is not indicated for postoperative general thoracic surgical patients with new-onset atrial fibrillation.
    Makhija Z; Allen MS; Wigle DA; Shen KR; Cassivi SD; Nichols FC; Deschamps C
    Ann Thorac Surg; 2011 Aug; 92(2):421-6; discussion 426-7. PubMed ID: 21801903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
    Poli D; Antonucci E; Marcucci R; Fatini C; Alterini B; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Thromb Res; 2007; 121(3):347-52. PubMed ID: 17597186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
    Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG;
    Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
    Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S
    Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Ibáñez CL; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
    Am J Cardiol; 2011 May; 107(10):1489-93. PubMed ID: 21420049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG; Albers GW
    J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral anticoagulant use in patients with atrial fibrillation].
    Ertaş F; Duygu H; Acet H; Eren NK; Nazli C; Ergene AO
    Turk Kardiyol Dern Ars; 2009 Apr; 37(3):161-7. PubMed ID: 19553738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    J Am Coll Cardiol; 2009 Sep; 54(11):999-1002. PubMed ID: 19729116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
    To AC; Yehia M; Collins JF
    Nephrology (Carlton); 2007 Oct; 12(5):441-7. PubMed ID: 17803466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S
    Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
    Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
    Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials.
    Albers GW;
    Am J Manag Care; 2004 Dec; 10(14 Suppl):S462-9; discussion S469-73. PubMed ID: 15696910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: efficacy and safety in actual clinical practice.
    Ono A; Fujita T
    J Clin Neurosci; 2005 Nov; 12(8):891-4. PubMed ID: 16271478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial.
    Apostolakis S; Guo Y; Lane DA; Buller H; Lip GY
    Eur Heart J; 2013 Dec; 34(46):3572-9. PubMed ID: 23966309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.